Fuller Walter L, Hamzat Omotayo T, Aboderin Aaron O, Gahimbare Laetitia, Kapona Otridah, Yahaya Ali A, Kasambara Watipaso, Nikiema Jean-Baptiste, Ilboudo Didier W, Mpundu Mirfin M
World Health Organization Regional Office for Africa, Brazzaville, Congo.
Universal Health Coverage/Life Course Cluster, World Health Organization, Abuja, Nigeria.
J Public Health Afr. 2022 Jul 27;13(2):2000. doi: 10.4081/jphia.2022.2000. eCollection 2022 Jul 26.
In line with global instruments, within the last five years, two-thirds of all countries in the WHO Africa Region (WHO AFR) have developed a National Action Plan (NAP) on Antimicrobial Resistance (AMR). We sought to evaluate progress made across the countries implementing NAP for effective response to AMR. A semi-structured survey tool was administered to obtain information from national focal persons on the implementation of strategic elements of NAP on AMR. This was followed by a Lessons Learnt Workshop in June 2019 at Douala, Cameroon, where focal persons made presentations on the country's progress. Later, a desktop review of the LLW report and other key documents was conducted. Countries in WHO AFR that have set up a national surveillance system and are enrolled into the WHO global antimicrobial resistance surveillance system have progressively increased to 30 (of 47 countries), of which 15 are already submitting surveillance data. Of the 20 countries at the Lessons Learnt Workshop, 14 have infection prevention and control (IPC) policies and functional healthcare facility IPC programs, 15 participate in the commemoration of the annual world hand hygiene days. Although almost all countries surveyed have national standard treatment guidelines, only five have incorporated the WHO AWaRe classification into the national essential medicines list. Fourteen of 20 countries have established an active/functional national secretariat/coordinating center for AMR. Discernible progress is being made on the implementation of NAP in WHO AFR region. Gaps identified in the strategic elements of action plans need to be filled for effective AMR control.
根据全球相关文件,在过去五年中,世卫组织非洲区域(WHO AFR)三分之二的国家制定了抗微生物药物耐药性(AMR)国家行动计划(NAP)。我们试图评估各国在实施国家行动计划以有效应对抗微生物药物耐药性方面取得的进展。我们使用了一个半结构化的调查工具,从各国的联络人那里获取关于抗微生物药物耐药性国家行动计划战略要素实施情况的信息。随后,于2019年6月在喀麦隆杜阿拉举办了一次经验教训研讨会,联络人在会上介绍了各国的进展情况。之后,对经验教训研讨会报告和其他关键文件进行了案头审查。在世卫组织非洲区域,已建立国家监测系统并加入世卫组织全球抗微生物药物耐药性监测系统的国家已逐步增加到30个(共47个国家),其中15个国家已经在提交监测数据。在参加经验教训研讨会的20个国家中,14个国家有感染预防与控制(IPC)政策和运转正常的医疗机构感染预防与控制项目,15个国家参与年度世界手卫生日的纪念活动。尽管几乎所有接受调查的国家都有国家标准治疗指南,但只有五个国家将世卫组织的AWaRe分类纳入了国家基本药物清单。20个国家中有14个国家设立了活跃/运转正常的国家抗微生物药物耐药性秘书处/协调中心。世卫组织非洲区域在实施国家行动计划方面正在取得明显进展。需要填补行动计划战略要素中发现的差距,以有效控制抗微生物药物耐药性。